Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.63 +1.14 (+3.87%)

Streaming Delayed Price Updated: 9:49 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings ↗

January 29, 2025

The Senate will meet Wednesday to start the confirmation hearing process for Robert F. Kennedy Jr.

Via Investor's Business Daily

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

January 29, 2025

Via ACCESS Newswire

3 ETFs Shine As Trump's First Week Sparks Record Gains Followed By Tech Slump ↗

January 28, 2025

The S&P 500 had a strong first week, with ETFs such as SPY, VOO and IVV seeing gains. Were Trump's economic policies a factor?

Via Benzinga

Topics ETFs Government Stocks

Top S&P500 movers in Tuesday's session ↗

January 28, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

How Is The Market Feeling About Moderna? ↗

January 28, 2025

Via Benzinga

3 Things You Need to Know if You Buy Moderna Today ↗

January 25, 2025

Via The Motley Fool

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

January 24, 2025

Via ACCESS Newswire

Moderna Unusual Options Activity For January 22 ↗

January 22, 2025

Via Benzinga

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? ↗

January 28, 2025

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald...

Via Benzinga

Topics Government

ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Week ↗

January 27, 2025

Global economy and financial markets saw a lot of activity in Jan. 24 week. S&P 500 reached record high, several ETFs had double-digit gains.

Via Benzinga

Topics ETFs Economy Stocks

10 Worst Performing Large-Caps Last 12 Months ↗

January 27, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? ↗

January 26, 2025

12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts.

Via Benzinga

Why Is Moderna Stock Trading Higher On Tuesday? ↗

January 21, 2025

Moderna secures $590 million from HHS for mRNA flu vaccine development.

Via Benzinga

Where Will Moderna Be in 3 Years? ↗

January 21, 2025

Via The Motley Fool

Why Moderna Stock Jumped Over 20% This Week ↗

January 25, 2025

Are you ready for artificial intelligence (AI)-driven mRNA vaccines?

Via The Motley Fool

Topics Artificial Intelligence

3 Beaten-Down Stocks That Haven't Been This Cheap in More Than 3 Years: Are They Bargain Buys? ↗

January 25, 2025

Via The Motley Fool

Trump Sparks Records On Wall Street, AI Stargate Project Lifts Chipmakers; Inflation, Tariff Jitters Arise: This Week In The Market ↗

January 24, 2025

Wall Street hit new records as Donald Trump began his second term as 47th U.S. president this week.

Via Benzinga

Topics Artificial Intelligence Economy Government

Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High ↗

January 24, 2025

The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats.

Via Stocktwits

Moderna Secures European Contract For Covid-19 Vaccine ↗

January 24, 2025

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to enhance healthcare delivery.

Via Benzinga

Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots ↗

January 24, 2025

Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.

Via Investor's Business Daily

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads ↗

January 24, 2025

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop.

Via Benzinga

Topics Government

Moderna Shares Are Up Today: What's Going On? ↗

January 23, 2025

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

Via Benzinga

Topics Artificial Intelligence

Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines ↗

January 22, 2025

Ellison, Oracle's chairman, pointed to the use of AI to develop drugs like Moderna's cancer vaccine.

Via Investor's Business Daily

Topics Artificial Intelligence

These 3 Stocks Are Down to Start 2025. What's Going On? ↗

January 22, 2025

Sonos, Moderna, and Shake Shack are all staring at some near-term headwinds – can they work through them?

Via The Motley Fool

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

After a Reset Year, Is Moderna Stock Poised for a Comeback?

January 22, 2025

Moderna had a rough 2024 and is starting 2025 with lowered forecasts, but is focused on getting 10 FDA approvals in the next three years. Is now time to buy?

Via MarketBeat

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine ↗

January 21, 2025

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.

Via Benzinga

Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump ↗

January 21, 2025

In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older.

Via Stocktwits

Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗

January 21, 2025

Via Benzinga

3M, Netflix And 3 Stocks To Watch Heading Into Tuesday ↗

January 21, 2025

US stock futures trading higher on Tuesday. Stocks to watch: 3M, D.R. Horton, Moderna, United Airlines, Netflix.

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.